STAA Q4 2019 Earnings — STAAR Surgical Company Revenue & Financial Results | Market Cap Arena

STAASTAAR Surgical Company

$871M

Q4 2019 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$39M+24.7% YoY

Gross Profit

$29M74.1% margin

Operating Income

$2M6.0% margin

Net Income

$6M16.4% margin

EPS (Diluted)

$0.14

QoQ Revenue Growth

-0.4%

Cash Flow

Operating Cash Flow

$10M

Free Cash Flow

$7M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$208M

Total Liabilities

$48M

Stockholders' Equity

$160M

Cash & Equivalents

$120M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$39M	$31M	+24.7%
Gross Profit	$29M	$23M	+25.4%
Operating Income	$2M	$1M	+97.3%
Net Income	$6M	$1M	+482.0%

Revenue Segments

Implantable Collamer Lenses

$33M86%

Intraocular Lenses

$4M10%

Other Surgical Products

$2M5%